1. Home
  2. Advocacy
  3. Latest News and Practice Data
  4. Reminder: Viral Hemorrhagic Fever Hospital Survey Ends March 20

A brief survey from the Centers for Disease Control and Prevention (CDC), the CAP, the Association for Molecular Pathology (AMP), Association of Public Health Laboratories (APHL), American Society for Microbiology (ASM), and COLA (Commission on Office Laboratory Accreditation) is being distributed to better understand the existing policies and practices in U.S. hospitals related to performing routine clinical laboratory testing on patients suspected of having a viral hemorrhagic fever (VHF). This survey is being distributed through the CAP’s partnership with the CDC, and will inform future policy and educational resources on this issue for US hospitals and the clinical laboratory community.

If you work in a hospital system, please forward this link to anyone who may be able to provide valuable insight on this topic. It should take less than 10 minutes to complete. The deadline for responses is March 20, 2024. Viral Hemorrhagic Fever survey

Most Recent Content

  1. October 14, 2025
  2. CAP opposes gene patent bill, citing harms to health care and innovation
  3. Ongoing government shutdown hits FDA, CDC staffing, programs
  4. CAP board appoints Akshay Patel as interim CEO starting later this month
  5. Online media training sessions planned in November, December
  6. View All